News | News By Subject | News by Disease News By Date | Search News

Drug / Clinical Trial News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Saga Continues for Sarepta (SRPT) as FDA Head Calls for Retraction of 'Misleading' 2013 Study     9/23/2016
This Biotech Has the Upper Hand Over Allergan (AGN) and Gilead (GILD) in the Heated Nash Battle     9/23/2016
H. Lundbeck A/S (LUN.CO)'s Phase III Data Crushes Hope for Alzheimer’s Once Again     9/23/2016
35 U.S. States Sue British Drugmaker Indivior Over Marketing of Opioid     9/23/2016
Gilead (GILD) Terminates Phase II/III Study of Ulcerative Colitis Drug     9/22/2016
Investors Beware: Thin CAR-T Data Could Make or Break Juno (JUNO) and Kite Pharma (KITE)     9/22/2016
Pharma Bro Warned You: Mast Therapeutics (MSTX) Craters After Drug Flunks Phase III Test, Job Cuts Expected     9/22/2016
Meet the Powerful Woman Behind the Scenes of Sarepta (SRPT)'s DMD Drug Approval     9/21/2016
The Drugmaker That Could Knock Gilead (GILD) Off Its HIV Throne     9/20/2016
How Ionis Pharma (IONS) is Beating the Pants Off of Competitors Like Alnylam (ALNY), Arrowhead Pharma (ARWR) and Moderna     9/20/2016
Will Biogen (BIIB)’s Alzheimer’s Drug Be a Miracle Drug or Just Another Bomb?     9/20/2016
Another Good Day for Amgen (AMGN) as Repatha Phase III GLAGOV Trial Met Primary, Secondary Endpoints     9/20/2016
FDA Places Clinical Hold on AML Drug Co-Developed by Johnson & Johnson (JNJ) and Genmab A/S (GEN.CO)     9/20/2016
Victory at Last! Sarepta (SRPT) Stock Doubles as the FDA Finally Approves DMD Drug     9/20/2016
Amgen (AMGN), UCB Group (UCBJF.PK)'s Romosozumab Showed Significant Results in Phase III Study     9/19/2016

Featured Stories
Biotech School: How To Spot Hidden Danger Signs In Clinical Trial Data     9/23/2016
A Look at Silcon Valley's Quest to Cure Diseases and End Aging     9/23/2016
Humans Shown To Have A Real Sixth Sense, NIH Study     9/23/2016
Meet The EpiPencil: The $30 DIY EpiPen Alternative Created By Pharma Hackers     9/23/2016
Smoke Gets In Your Genes, National Institute of Environmental Health Sciences Study     9/23/2016
Medical Marijuana Seems To Reduce Deaths From Pharmaceuticals     9/23/2016
8 Weird Headache Causes: Hairstyles, Fragrances, Brain Freezes And Other Triggers You Didn’t Know     9/22/2016
Sleep Well At 11 And Kick The Substances Out In Your Teens, University of Pittsburgh Study     9/22/2016
Many Doctors Don't Prescribe Medication For Opioid Addiction Despite Epidemic     9/22/2016
Theranos's Arizona Lab Still Open Despite Violations     9/22/2016
Mylan (MYL)'s First Date With Congress Proves "Painful"     9/22/2016
Drugmakers Attack NASH Liver Illness From All Sides     9/21/2016
Surprise! Beer Makes You Happier, Friendlier, University Hospital in Basel Study     9/21/2016
Inside The 10-Year, $1 Billion Battle For The Next Critical Antibiotic     9/21/2016
This Coffee Has An Ingredient Similar To Viagra     9/21/2016

More News
Findings From AcelRx (ACRX)' Phase 3 SAP301 Study Of ARX-04 In Abdominoplasty Patients To Be Presented At Plastic Surgery Meeting     9/23/2016
AbbVie (ABBV) Presents Data On Eight-Week Treatment Of VIEKIRAX (Ombitasvir/Paritaprevir/Ritonavir Tablets) + EXVIERA (Dasabuvir Tablets) In Patients With Genotype 1b Chronic Hepatitis C     9/23/2016
Armed With Fresh Phase III Data, Novartis AG (NVS) Eyes First-Line Use for Lung Cancer Drug Zykadia     9/23/2016
Fundación MAPFRE Presents The Results Of Personalized Cell Therapy For Treating Spinal Cord Injury     9/23/2016
Enanta Pharmaceuticals, Inc. Announces Data On Eight-Week Treatment Of AbbVie (ABBV)’s VIEKIRAX (Ombitasvir/Paritaprevir/Ritonavir Tablets) + EXVIERA (Dasabuvir Tablets) In Patients With Genotype 1b Chronic Hepatitis C     9/23/2016
Nordic Nanovector: Safety Review Committee Supports Dose Escalation With Betalutin In Lymrit 37-01 Trial Pending Safety Data From Cohort Receiving Higher Pre-Dosing     9/23/2016
Entasis Announces Positive Phase 2 Data Of ETX0914 For The Treatment Of Gonorrhea     9/23/2016
Janssen Biotech (JNJ) Submits Application Seeking Approval Of Sirukumab In United States For Rheumatoid Arthritis     9/23/2016
Kerastem Completes Enrollment in US Phase II Hair Growth Clinical Trial     9/23/2016
Medivir (MVRBF): MIV-711 Osteoarthritis Trial: Recommendation To Go Ahead Based On Independent Review Of Safety Data, And First Patient Enrolled In Extension Study     9/23/2016
Kadmon Initiates Placebo-Controlled Phase 2 Clinical Trial Evaluating KD025 In Psoriasis     9/23/2016
Kadmon Initiates Phase 2 Clinical Trial Evaluating KD025 In Chronic Graft-Versus Host Disease     9/23/2016
Faraday Pharma Announces First-In-Human Trial Of FDY-5301     9/23/2016
Salk Institute for Biological Studies Release: Targeting Fat To Treat Cancer     9/23/2016
Human Microbiology Institute Release: New Research Indicates Alzheimer's and Other Neurodegenerative Diseases Are Contagious     9/23/2016

Career Tips
Biotech vs. Big Pharma: Which is the Better Place to Work?     9/22/2016
What's Going On With The Biotech Job Market?     9/22/2016
Why People Are Angry at This Wells Fargo Ad About Scientists     9/9/2016
Meet the Next Wave of Scientists Who Are Taking Over Biotech     9/9/2016
These Biotech Employers Hired the Most New Grads In Life Sciences     8/25/2016
Best Places to Work in Life Sciences for LGBT Equality     8/25/2016
Biotech Startup Practichem Is Buying Tesla Cars for Its Employees     8/15/2016
Attention Grads: Here’s What You Need to Know About the Biotech Job Market     8/12/2016
Job Seekers Take Note: Challenges Faced by Life Science Employers     7/29/2016
Brexit Schmexit: What This Mess Means for Life Science Jobs     7/29/2016
The ROI of Gratitude: Two Biotechs Getting It Right     7/18/2016
Top 14 Life Science Jobs in California     7/14/2016
Top 5 Bay Area Biomed Hot Spots     6/30/2016
Inside the Biotech Employer's Head: Job Interview Questions That You Should Be Ready to Answer     6/16/2016
What’s at the Heart of Alnylam (ALNY)'s Company Culture?     6/3/2016

Other News Sources
//-->